{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:21:27Z","timestamp":1786119687051,"version":"build-2736575974"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1097\/med.0b013e328248b498","type":"journal-article","created":{"date-parts":[[2011,1,14]],"date-time":"2011-01-14T01:57:37Z","timestamp":1294970257000},"page":"323-328","source":"Crossref","is-referenced-by-count":20,"title":["Second-line treatment for Cushing's disease when initial pituitary surgery is unsuccessful"],"prefix":"10.1097","volume":"14","author":[{"given":"Maria","family":"Fleseriu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D Lynn","family":"Loriaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H","family":"Ludlam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20211004","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ecl.2005.01.010","article-title":"The metabolic syndrome and cardiovascular risk in Cushings syndrome.","volume":"34","author":"Pivonello","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R2-12-20211004","first-page":"553","article-title":"Controversies in the management of Cushing's disease","volume":"33","author":"Chandler","year":"1986","journal-title":"Clin Neurosurg"},{"key":"R3-12-20211004","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1046\/j.1365-2265.2001.01261.x","article-title":"Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?","volume":"54","author":"Chee","year":"2001","journal-title":"Clin Endocrinol"},{"key":"R4-12-20211004","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ecl.2005.01.007","article-title":"Pituitary surgery and postoperative management in Cushings disease.","volume":"34","author":"Utz","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R5-12-20211004","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2265.2005.02380.x","article-title":"Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance","volume":"63","author":"Atkinson","year":"2005","journal-title":"Clin Endocrinol"},{"key":"R6-12-20211004","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3171\/jns.1994.80.1.0037","article-title":"Early repeat surgery for persistent Cushing's disease","volume":"80","author":"Ram","year":"1994","journal-title":"J Neurosurg"},{"key":"R7-12-20211004","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3171\/jns.1989.71.4.0520","article-title":"Repeat transsphenoidal surgery for Cushing's disease","volume":"71","author":"Friedman","year":"1989","journal-title":"J Neurosurg"},{"key":"R8-12-20211004","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3171\/jns.2005.102.6.1004","article-title":"Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma","volume":"102","author":"Benveniste","year":"2005","journal-title":"J Neurosurg"},{"key":"R9-12-20211004","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1210\/jc.2004-2436","article-title":"Clinical review: the strategy of immediate reoperation for transsphenoidal surgery for Cushing's disease","volume":"90","author":"Locatelli","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-12-20211004","first-page":"1619","article-title":"Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas","volume":"83","author":"Katznelson","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-12-20211004","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/eje.0.1490195","article-title":"Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas","volume":"149","author":"Cannavo","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"R12-12-20211004","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3171\/jns.2005.103.5.0825","article-title":"Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndrome","volume":"103","author":"De Tommasi","year":"2005","journal-title":"J Neurosurg"},{"key":"R13-12-20211004","first-page":"1596","article-title":"Laparoscopic adrenalectomy for adrenocorticotropin-dependent Cushing's syndrome","volume":"86","author":"Vella","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R14-12-20211004","first-page":"440","article-title":"Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic\u2013Pituitary\u2013Adrenal Axis","volume":"84","author":"Invitti","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-12-20211004","first-page":"2647","article-title":"Risk factors and long-term outcome in pituitary-dependent Cushing's disease","volume":"81","author":"Sonino","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"R16-12-20211004","first-page":"165","article-title":"The long-term outcome after adrenalectomy and prophylactic pituitary radiotherapy in adrenocorticotropin-dependent Cushing's syndrome","volume":"80","author":"Jenkins","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-12-20211004","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/bmj.289.6446.643","article-title":"Treatment of Cushing's disease with low dose radiation therapy","volume":"289","author":"Ahmed","year":"1984","journal-title":"BMJ"},{"key":"R18-12-20211004","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2265.1990.tb03883.x","article-title":"Long-term follow-up of low-dose external pituitary irradiation for Cushing's disease","volume":"33","author":"Littley","year":"1990","journal-title":"Clin Endocrinol"},{"key":"R19-12-20211004","first-page":"281","article-title":"Clinical recurrence of Cushing syndrome without evidence of tumor recurrence: radical hypophysectomy?","volume":"48","author":"Estour","year":"2002","journal-title":"Neurochirurgie"},{"key":"R20-12-20211004","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3171\/jns.2004.100.4.0634","article-title":"Transsphenoidal surgery in Cushing disease: 10 years of experience in 34 consecutive cases","volume":"100","author":"Hoybye","year":"2004","journal-title":"J Neurosurg"},{"key":"R21-12-20211004","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3171\/jns.2005.102.4.0678","article-title":"Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium","volume":"102","author":"Sheehan","year":"2005","journal-title":"J Neurosurg"},{"key":"R22-12-20211004","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1023365200437","article-title":"Radiation therapy for Cushing's disease: a review","volume":"5","author":"Mahmoud-Ahmed","year":"2002","journal-title":"Pituitary"},{"issue":"Suppl 1","key":"R23-12-20211004","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000056413","article-title":"Pituitary tumors and gamma knife surgery. Clinical experience with more than two years of follow-up","volume":"70","author":"Martinez","year":"1998","journal-title":"Stereotact Funct Neurosurg"},{"key":"R24-12-20211004","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0360-3016(02)02975-9","article-title":"Stereotactic radiosurgery for patients with ACTH-producing pituitary adenomas after prior adrenalectomy","volume":"54","author":"Pollock","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R25-12-20211004","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1056\/NEJM199701163360303","article-title":"The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease","volume":"336","author":"Estrada","year":"1997","journal-title":"N Engl J Med"},{"key":"R26-12-20211004","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3171\/jns.2000.93.5.0738","article-title":"Radiosurgery for Cushing's disease after failed transsphenoidal surgery","volume":"93","author":"Sheehan","year":"2000","journal-title":"J Neurosurg"},{"key":"R27-12-20211004","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3171\/jns.2002.97.supplement_5.0644","article-title":"Gamma knife radiosurgery and its possible relationship to malignancy: a review","volume":"97","author":"Ganz","year":"2002","journal-title":"J Neurosurg"},{"key":"R28-12-20211004","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/edrv-14-4-443","article-title":"The medical treatment of Cushing's syndrome","volume":"14","author":"Miller","year":"1993","journal-title":"Endocr Rev"},{"key":"R29-12-20211004","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2265.1993.tb02391.x","article-title":"The relationship between cortisol production rate and serial serum cortisol estimation in patients on medical therapy for Cushing's syndrome","volume":"39","author":"Trainer","year":"1993","journal-title":"Clin Endocrinol"},{"key":"R30-12-20211004","first-page":"60","article-title":"ACTH response to corticotropin releasing hormone in Cushing's disease before and after ketoconazole: in vivo and in vitro studies","volume":"16","author":"Boscaro","year":"1987","journal-title":"Horm Metab Res Suppl"},{"key":"R31-12-20211004","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1507\/endocrj.47.401","article-title":"Long-term effects of ketoconazole in the treatment of residual or recurrent Cushing's disease","volume":"47","author":"Chou","year":"2000","journal-title":"Endocr J"},{"key":"R32-12-20211004","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1210\/jcem-63-6-1365","article-title":"Use of ketoconazole in the treatment of Cushing's syndrome","volume":"63","author":"Loli","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"R33-12-20211004","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2265.1987.tb01189.x","article-title":"Clinical experience with ketoconazole as a therapy for patients with Cushing's syndrome","volume":"27","author":"McCance","year":"1987","journal-title":"Clin Endocrinol"},{"key":"R34-12-20211004","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1210\/jcem-61-4-718","article-title":"Prolonged treatment of Cushing's disease by ketoconazole","volume":"61","author":"Sonino","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 3","key":"R35-12-20211004","first-page":"76","article-title":"New medical approaches in pituitary adenomas","volume":"53","author":"Colao","year":"2000","journal-title":"Horm Res"},{"key":"R36-12-20211004","first-page":"2885","article-title":"Additive effect of ketoconazole and octreotide in the treatment of severe adrenocorticotropin-dependent hypercortisolism","volume":"81","author":"Vignati","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"R37-12-20211004","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0960-0760(94)90267-4","article-title":"Therapy of Cushing's syndrome with steroid biosynthesis inhibitors","volume":"49","author":"Engelhardt","year":"1994","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R38-12-20211004","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1530\/eje.0.1300125","article-title":"Octreotide exerts different effects in vivo and in vitro in Cushing's disease","volume":"130","author":"Stalla","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"R39-12-20211004","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1126\/science.288.5463.154","article-title":"Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity","volume":"288","author":"Rocheville","year":"2000","journal-title":"Science"},{"key":"R40-12-20211004","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1507\/endocrj1954.39.385","article-title":"Beneficial effects of high daily dose bromocriptine treatment in Cushing's disease","volume":"39","author":"Mercado-Asis","year":"1992","journal-title":"Endocrinol Jpn"},{"key":"R41-12-20211004","first-page":"300","article-title":"Nelson's syndrome: complete remission with cabergoline but not with bromocriptine or cyproheptadine treatment","volume":"62","author":"Casulari","year":"2004","journal-title":"Horm Res"},{"key":"R42-12-20211004","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2265.1990.tb00855.x","article-title":"The effect of cyproheptadine and\/or bromocriptine on plasma ACTH levels in patients cured of Cushing's disease by bilateral adrenalectomy","volume":"32","author":"Whitehead","year":"1990","journal-title":"Clin Endocrinol"},{"key":"R43-12-20211004","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/BF03349875","article-title":"Cyproheptadine treatment in Cushing's disease","volume":"19","author":"Tanakol","year":"1996","journal-title":"J Endocrinol Invest"},{"key":"R44-12-20211004","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1210\/jcem-56-6-1094","article-title":"Effects of cyproheptadine, reserpine, and synthetic corticotropin-releasing factor on pituitary glands from patients with Cushing's disease","volume":"56","author":"Suda","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"R45-12-20211004","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF03347989","article-title":"Failure of long-term therapy with sodium valproate in Cushing's disease","volume":"20","author":"Colao","year":"1997","journal-title":"J Endocrinol Invest"},{"key":"R46-12-20211004","first-page":"3568","article-title":"Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486)","volume":"86","author":"Chu","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R47-12-20211004","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1530\/eje.1.01876","article-title":"The multiligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5","volume":"152","author":"Hofland","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"R48-12-20211004","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/BF03347485","article-title":"Novel medical approaches for the treatment of Cushing's disease","volume":"27","author":"Heaney","year":"2004","journal-title":"J Endocrinol Invest"},{"key":"R49-12-20211004","doi-asserted-by":"crossref","first-page":"8806","DOI":"10.1073\/pnas.95.15.8806","article-title":"Ligands for peroxisome proliferator-activated receptor-gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice","volume":"95","author":"Elstner","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R50-12-20211004","doi-asserted-by":"crossref","first-page":"RC8","DOI":"10.1007\/BF03345281","article-title":"Baseline and CRH-stimulated ACTH and cortisol levels after administration of the peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone, in Cushings disease.","volume":"27","author":"Cannavo","year":"2004","journal-title":"J Endocrinol Invest"},{"key":"R51-12-20211004","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/eje.0.1510173","article-title":"Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease","volume":"151","author":"Ambrosi","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"R52-12-20211004","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1172\/JCI11098","article-title":"Retinoic acid prevents experimental Cushing syndrome","volume":"108","author":"Paez-Pereda","year":"2001","journal-title":"J Clin Invest"},{"key":"R53-12-20211004","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1210\/me.2004-0471","article-title":"\u03b11-Adrenergic receptor antagonists: novel therapy for pituitary adenomas","volume":"19","author":"Fernando","year":"2005","journal-title":"Mol Endocrinol"}],"container-title":["Current Opinion in Endocrinology, Diabetes & Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01266029-200708000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:50:47Z","timestamp":1786042247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01266029-200708000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/med.0b013e328248b498","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}